Overexpression of nef as a marker for restricted HIV‐1 infection of astrocytes in postmortem pediatric central nervous tissues

In previous studies, using polymerase chain reaction amplification of HIV-1 genes directly from pathologic tissues of children who died with AIDS encephalopathy, we showed that the reading frame of the HIV-1 regulatory nef gene is open, suggesting that the nef protein was expressed. We now show, using immunocytoehemistry and in situ hybridization with nef-specific probes in postmortem pediatric CNS tissues, that nef mRNA and protein are present in up to 20% of astrocytes in tissue sections selected for extensive histopathology. By contrast, HIV-1 structural proteins such as gag and their coding mRNAs are present in multinucleated giant cells that harbor productive infection and are the hallmark of HIV-1 infection in the CNS. These findings are consistent with the nonproductive infection of glial cells observed in vitro, and imply that HIV-1 infection of astrocytes is restricted to early regulatory gene products, of which nef is the best target as it is expressed at high levels and is membrane-anchored. In developing central nervous tissues of children, restricted and latent HIV-1 infection of astrocytes may be extensive and contribute significantly to HIV-1 neuropathogenesis.

[1]  E. Major,et al.  HIV‐1 infection of subcortical astrocytes in the pediatric central nervous system , 1994, Neurology.

[2]  R. Desrosiers,et al.  Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. , 1992, Science.

[3]  V. Ovod,et al.  Cellular localization of Nef expressed in persistently HIV‐1 -infected low‐producer astrocytes , 1992, AIDS.

[4]  J. Goudsmit,et al.  Epitopes of human immunodeficiency virus regulatory proteins tat, nef, and rev are expressed in normal human tissue. , 1992, The American journal of pathology.

[5]  E. Masliah,et al.  Spectrum of human immunodeficiency virus–associated neocortical damage , 1992, Annals of neurology.

[6]  L. Epstein,et al.  Human immunodeficiency virus type 1 nef quasispecies in pathological tissue , 1992, Journal of virology.

[7]  G. Yu,et al.  Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription. , 1992, Virology.

[8]  A. Burny,et al.  Infection of human brain cells by HIV‐1: restricted virus production in chronically infected human glial cell lines , 1992, AIDS.

[9]  F. Gombert,et al.  Immunological variation and immunohistochemical localization of HIV‐1 Nef demonstrated with monoclonal antibodies , 1992, AIDS.

[10]  L. Sharer,et al.  Pathology of HIV‐1 Infection of the Central Nervous System. A review , 1992, Journal of neuropathology and experimental neurology.

[11]  E. Major,et al.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta , 1991, Journal of virology.

[12]  D. Dickson,et al.  Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. , 1991, Human pathology.

[13]  B. Cullen The positive effect of the negative factor , 1991, Nature.

[14]  E. Masliah,et al.  Neocortical damage during HIV infection , 1991, Annals of neurology.

[15]  R. Desrosiers,et al.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS , 1991, Cell.

[16]  P. Lantos,et al.  Neuronal loss in the frontal cortex in HIV infection , 1991, The Lancet.

[17]  P. Lantos,et al.  HIV‐Associated Disease of the Nervous System: Review of Nomenclature and Proposal for Neuropathology‐Based Terminology , 1991, Brain pathology.

[18]  P. J. Clarke,et al.  The immunolocalisation of the neuroendocrine specific protein PGP9.5 during neurogenesis in the rat. , 1991, Brain research. Developmental brain research.

[19]  L. Epstein,et al.  Spinal cord disease in children with HIV‐1 infection: a combined molecular biological and neuropathological study * , 1990, Neuropathology and applied neurobiology.

[20]  N. Sarver,et al.  Expression and biochemical characterization of human immunodeficiency virus type 1 nef gene product , 1990, Journal of virology.

[21]  M. Reitz,et al.  Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages , 1990, Journal of virology.

[22]  D. Baltimore,et al.  Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency , 1990, Cell.

[23]  E. Fenyö,et al.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1 , 1990, Journal of virology.

[24]  F. Gombert,et al.  Antigenic epitopes of NEF proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection. , 1990, Virology.

[25]  D. Dickson,et al.  Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. , 1990, The American journal of pathology.

[26]  C. Cheng‐Mayer,et al.  Differential effects of nef on HIV replication: implications for viral pathogenesis in the host. , 1989, Science.

[27]  M. Malim,et al.  Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  C. Kunsch,et al.  Transient expression of human immunodeficiency virus type 1 genome results in a nonproductive infection in human fetal dorsal root ganglia glial cells. , 1989, Virology.

[29]  K D Wilkinson,et al.  The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. , 1989, Science.

[30]  D. Baltimore,et al.  Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression , 1989, Journal of virology.

[31]  H. Gendelman,et al.  The macrophage in the persistence and pathogenesis of HIV infection. , 1989, AIDS.

[32]  L. Montagnier,et al.  Use of synthetic peptides for the detection of antibodies against the nef regulating protein in sera of HIV-infected patients. , 1989, AIDS (London).

[33]  S. Dewhurst,et al.  Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV , 1987, Journal of virology.

[34]  B. Guy,et al.  HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product , 1987, Nature.

[35]  C. Cordon-Cardo,et al.  HIV antigen in the brains of patients with the AIDS dementia complex , 1987, Annals of neurology.

[36]  F. Chiodi,et al.  Infection of brain-derived cells with the human immunodeficiency virus , 1987, Journal of virology.

[37]  J. Ghrayeb,et al.  Cytoplasmic localization of the HTLV-III 3' orf protein in cultured T cells. , 1986, Virology.

[38]  H. Gendelman,et al.  Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. , 1986, Science.

[39]  C. Wiley,et al.  Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[40]  E. Cho,et al.  Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain. , 1986, Human pathology.

[41]  Michael S. B. Edwards,et al.  A Trojan Horse mechanism for the spread of visna virus in monocytes. , 1985, Virology.

[42]  E. Cho,et al.  Multinucleated giant cells and HTLV-III in AIDS encephalopathy. , 1985, Human pathology.

[43]  J. Oleske,et al.  Progressive encephalopathy in children with acquired immue deficiency syndrome , 1985, Annals of neurology.

[44]  G. Shaw,et al.  HTLV-III infection in brains of children and adults with AIDS encephalopathy. , 1985, Science.

[45]  A. Dhillon,et al.  PGP 9.5—a new marker for vertebrate neurons and neuroendocrine cells , 1983, Brain Research.

[46]  E. Cho,et al.  Neuropathology of HIV infection: adults versus children. , 1989, Progress in AIDS pathology.

[47]  R. Rhodes,et al.  Immunohistochemical localization of human immunodeficiency viral antigens in formalin-fixed spinal cords with AIDS myelopathy. , 1989, Clinical neuropathology.

[48]  L. Epstein,et al.  Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. , 1988, Immunodeficiency reviews.

[49]  H. Gendelman,et al.  IN SITU HYBRIDIZATION FOR DETECTION OF VIRAL NUCLEIC ACID IN CELL CULTURES AND TISSUES , 1986 .

[50]  B. Navia,et al.  HTLV-III/LAV-like retrovirus particles in the brains of patients with AIDS encephalopathy. , 1984, AIDS research.